{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:45:13Z","timestamp":1793303113594,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2016YFC1305800"],"award-info":[{"award-number":["2016YFC1305800"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007046","name":"Wuhan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91949205"],"award-info":[{"award-number":["91949205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230041"],"award-info":[{"award-number":["82230041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31730035"],"award-info":[{"award-number":["31730035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81721005"],"award-info":[{"award-number":["81721005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230041,91949205"],"award-info":[{"award-number":["82230041,91949205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.scib.2024.01.019","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T18:39:32Z","timestamp":1705689572000},"page":"1137-1152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer\u2019s disease and related tauopathies"],"prefix":"10.1016","volume":"69","author":[{"given":"Jingfen","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2024.01.019_b0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","article-title":"Tauopathies: New perspectives and challenges","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol Neurodegeneration"},{"key":"10.1016\/j.scib.2024.01.019_b0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.scib.2024.01.019_b0015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd.2017.155","article-title":"Tau-based therapies in neurodegeneration: Opportunities and challenges","volume":"16","author":"Li","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.scib.2024.01.019_b0020","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1021\/acs.jmedchem.2c00316","article-title":"Beyond Proteolysis-Targeting Chimeric Molecules: Designing heterobifunctional molecules based on functional effectors","volume":"65","author":"Hua","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2024.01.019_b0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: The past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.scib.2024.01.019_b0030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","article-title":"AUTACs: Cargo-specific degraders using selective autophagy","volume":"76","author":"Takahashi","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.scib.2024.01.019_b0035","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41467-022-28520-4","article-title":"The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system","volume":"13","author":"Ji","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2024.01.019_b0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/15548627.2019.1688556","article-title":"ATTEC: A potential new approach to target proteinopathies","volume":"16","author":"Li","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.scib.2024.01.019_b0045","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41589-021-00851-1","article-title":"Bifunctional small molecules that mediate the degradation of extracellular proteins","volume":"17","author":"Caianiello","year":"2021","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.scib.2024.01.019_b0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-022-05235-6","article-title":"Antibody targeting of E3 ubiquitin ligases for receptor degradation","volume":"610","author":"Marei","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.scib.2024.01.019_b0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/jacs.0c10008","article-title":"Development of antibody-based PROTACs for the degradation of the cell-surface immune checkpoint protein PD-L1","volume":"143","author":"Cotton","year":"2021","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.scib.2024.01.019_b0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chembiol.2016.02.016","article-title":"Specific knockdown of endogenous tau protein by peptide-directed ubiquitin-proteasome degradation","volume":"23","author":"Chu","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejmech.2018.01.063","article-title":"Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway","volume":"146","author":"Lu","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.scib.2024.01.019_b0075","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.7150\/thno.55680","article-title":"A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.scib.2024.01.019_b0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41392-021-00669-2","article-title":"A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies","volume":"6","author":"Zheng","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.scib.2024.01.019_b0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/gb-2004-6-1-204","article-title":"The MAP2\/Tau family of microtubule-associated proteins","volume":"6","author":"Dehmelt","year":"2005","journal-title":"Genome Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.2613","article-title":"Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export","volume":"18","author":"Lei","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.scib.2024.01.019_b0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.scib.2024.01.019_b0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","article-title":"Serine\/threonine phosphatases: Mechanism through structure","volume":"139","author":"Shi","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.scib.2024.01.019_b0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: Involvement in Alzheimer\u2019s disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.scib.2024.01.019_b0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arr.2012.06.008","article-title":"Tau protein phosphatases in Alzheimer\u2019s disease: The leading role of PP2A","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.scib.2024.01.019_b0115","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1093\/emboj\/17.24.7179","article-title":"FRET microscopy demonstrates molecular association of non-specific lipid transfer protein (nsL-TP) with fatty acid oxidation enzymes in peroxisomes","volume":"17","author":"Wouters","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.scib.2024.01.019_b0120","doi-asserted-by":"crossref","first-page":"54518","DOI":"10.1074\/jbc.M408186200","article-title":"Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis","volume":"279","author":"Rametti","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2024.01.019_b0125","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1073\/pnas.1417548111","article-title":"SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination","volume":"111","author":"Luo","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2024.01.019_b0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-2006-9S326","article-title":"Tau phosphorylation and proteolysis: Insights and perspectives","volume":"9","author":"Johnson","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.scib.2024.01.019_b0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chembiol.2009.02.012","article-title":"Docking motif-guided mapping of the interactome of protein phosphatase-1","volume":"16","author":"Hendrickx","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0140","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.molcel.2016.06.024","article-title":"A conserved motif provides binding specificity to the PP2A-B56 phosphatase","volume":"63","author":"Hertz","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.scib.2024.01.019_b0145","doi-asserted-by":"crossref","first-page":"14984","DOI":"10.1074\/jbc.M111.338681","article-title":"The protein phosphatase PP2A\/B\u03b1 binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn","volume":"287","author":"Sontag","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2024.01.019_b0150","article-title":"A dynamic charge-charge interaction modulates PP2A:B56 substrate recruitment","volume":"9","author":"Wang","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.scib.2024.01.019_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001492","article-title":"The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin","volume":"11","author":"Grigoriu","year":"2013","journal-title":"PLoS Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0160","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.molcel.2007.02.014","article-title":"A conserved docking site modulates substrate affinity for calcineurin, signaling output, and in vivo function","volume":"25","author":"Roy","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.scib.2024.01.019_b0165","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1016-8478(23)17095-6","article-title":"Efficient intracellular delivery of an exogenous protein GFP with genetically fused basic oligopeptides","volume":"12","author":"Han","year":"2001","journal-title":"Mol Cells"},{"key":"10.1016\/j.scib.2024.01.019_b0170","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/j.1460-2075.1988.tb03033.x","article-title":"Differential interaction of synthetic peptides from the carboxyl-terminal regulatory domain of tubulin with microtubule-associated proteins","volume":"7","author":"Maccioni","year":"1988","journal-title":"EMBO J"},{"key":"10.1016\/j.scib.2024.01.019_b0175","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.85.16.6092","article-title":"Anti-idiotypic antibodies that react with microtubule-associated proteins are present in the sera of rabbits immunized with synthetic peptides from tubulin\u2019s regulatory domain","volume":"85","author":"Rivas","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2024.01.019_b0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10154","article-title":"Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation","volume":"475","author":"Sievers","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.scib.2024.01.019_b0185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchem.2889","article-title":"Structure-based inhibitors of tau aggregation","volume":"10","author":"Seidler","year":"2018","journal-title":"Nature Chem"},{"key":"10.1016\/j.scib.2024.01.019_b0190","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fnins.2018.00444","article-title":"Exposure to di-(2-ethylhexyl) phthalate during perinatal period gender-specifically impairs the dendritic growth of pyramidal neurons in rat offspring","volume":"12","author":"You","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.scib.2024.01.019_b0195","first-page":"2228","article-title":"Stabilization of microtubular cytoskeleton protects neurons from toxicity of N-terminal fragment of cytosolic prion protein","volume":"1853","author":"Zajkowski","year":"2015","journal-title":"BBA-Mol Cell Res"},{"key":"10.1016\/j.scib.2024.01.019_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101636","article-title":"Neurogenesis in aging and age-related neurodegenerative diseases","volume":"78","author":"Culig","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.scib.2024.01.019_b0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.stem.2019.12.015","article-title":"Interneuron accumulation of phosphorylated tau impairs adult hippocampal neurogenesis by suppressing GABAergic transmission","volume":"26","author":"Zheng","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.scib.2024.01.019_b0210","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.3390\/ijms22094914","article-title":"Calcium dyshomeostasis in Alzheimer\u2019s disease pathogenesis","volume":"22","author":"Cascella","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.scib.2024.01.019_b0215","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: Past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.scib.2024.01.019_b0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","article-title":"Allele-selective lowering of mutant HTT protein by HTT\u2013LC3 linker compounds","volume":"575","author":"Li","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.scib.2024.01.019_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100647","article-title":"Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs","volume":"296","author":"Alabi","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2024.01.019_b0230","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","article-title":"Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation","volume":"22","author":"Liu","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.scib.2024.01.019_b0235","doi-asserted-by":"crossref","first-page":"25490","DOI":"10.1074\/jbc.274.36.25490","article-title":"Molecular interactions among protein phosphatase 2A, Tau, and microtubules","volume":"274","author":"Sontag","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2024.01.019_b0240","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.tips.2020.08.008","article-title":"Nanoformulation of BRD4-Degrading PROTAC: Improving druggability to target the \u2018undruggable\u2019 MYC in pancreatic cancer","volume":"41","author":"Minko","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.scib.2024.01.019_b0245","doi-asserted-by":"crossref","first-page":"11615","DOI":"10.1021\/acs.jmedchem.0c00793","article-title":"Understanding the metabolism of roteolysis Targeting Chimeras (PROTACs): The next step toward pharmaceutical applications","volume":"63","author":"Goracci","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2024.01.019_b0250","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/anie.201507634","article-title":"Modular PROTAC design for the degradation of oncogenic BCR-ABL","volume":"55","author":"Lai","year":"2016","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.scib.2024.01.019_b0255","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acschembio.5b00442","article-title":"HaloPROTACS: Use of small molecule PROTACs to induce degradation of HaloTag fusion proteins","volume":"10","author":"Buckley","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0260","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/pro.5560071011","article-title":"Construction, expression, and characterization of a novel fully activated recombinant single-chain hepatitis C virus protease","volume":"7","author":"Taremi","year":"1998","journal-title":"Protein Sci"},{"key":"10.1016\/j.scib.2024.01.019_b0265","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2016.06.038","article-title":"The effect of linker type and recognition peptide conjugation chemistry on tissue affinity and cytotoxicity of charged polyacrylamide","volume":"257","author":"Bloch","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.scib.2024.01.019_b0270","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/pro.2206","article-title":"Linkers in the structural biology of protein-protein interactions: Linkers in structural biology","volume":"22","author":"Reddy Chichili","year":"2013","journal-title":"Protein Sci"},{"key":"10.1016\/j.scib.2024.01.019_b0275","first-page":"115","article-title":"Delineating the role of cooperativity in the design of potent PROTACs for BTK","author":"Zorba","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2024.01.019_b0280","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/anie.201507634","article-title":"Modular PROTAC design for the degradation of oncogenic BCR-ABL","volume":"55","author":"Ashton","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.scib.2024.01.019_b0285","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.scib.2024.01.019_b0290","doi-asserted-by":"crossref","first-page":"381","DOI":"10.37349\/etat.2020.00023","article-title":"Novel approaches for the rational design of PROTAC linkers","volume":"1","author":"Zagidullin","year":"2020","journal-title":"Explor Target Antitumor Ther"},{"key":"10.1016\/j.scib.2024.01.019_b0295","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijpharm.2016.01.068","article-title":"Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration","volume":"501","author":"Li","year":"2016","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.scib.2024.01.019_b0300","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: Classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.scib.2024.01.019_b0305","doi-asserted-by":"crossref","first-page":"D1098","DOI":"10.1093\/nar\/gkv1266","article-title":"CPPsite 2.0: A repository of experimentally validated cell-penetrating peptides","volume":"44","author":"Agrawal","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.scib.2024.01.019_b0310","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acschembio.5b01006","article-title":"A potent d-protein antagonist of VEGF-A is nonimmunogenic, metabolically stable, and longer-circulating in vivo","volume":"11","author":"Uppalapati","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","article-title":"Targeted protein degradation: Elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0320","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chembiol.2017.09.010","article-title":"Lessons in PROTAC Design from Selective degradation with a promiscuous warhead","volume":"25","author":"Bondeson","year":"2018","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ddtec.2019.01.002","article-title":"PROteolysis TArgeting Chimeras (PROTACs) \u2014 Past, present and future","volume":"31","author":"Pettersson","year":"2019","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.scib.2024.01.019_b0330","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00401-017-1674-1","article-title":"Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment","volume":"133","author":"Hatch","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.scib.2024.01.019_b0335","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1083\/jcb.200108057","article-title":"Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress","volume":"156","author":"Stamer","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.scib.2024.01.019_b0340","doi-asserted-by":"crossref","DOI":"10.1126\/science.1194653","article-title":"Tau reduction prevents A\u03b2-induced defects in axonal transport","volume":"330","author":"Vossel","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.scib.2024.01.019_b0345","first-page":"113","article-title":"Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV\/CREB signaling","author":"Yin","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2024.01.019_b0350","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1038\/sj.emboj.7601917","article-title":"Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau","volume":"26","author":"Kimura","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.scib.2024.01.019_b0355","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/369488a0","article-title":"Altered microtubule organization in small-calibre axons of mice lacking tau protein","volume":"369","author":"Harada","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.scib.2024.01.019_b0360","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: An emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.scib.2024.01.019_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063236","article-title":"Engineered monoclonal antibody with novel antigen-sweeping activity in vivo","volume":"8","author":"Igawa","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.scib.2024.01.019_b0370","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0076-6879(05)99054-X","article-title":"Chimeric molecules to target proteins for ubiquitination and degradation","volume":"399","author":"Sakamoto","year":"2005","journal-title":"Method Enzymol"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927324000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927324000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:40:46Z","timestamp":1778838046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927324000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2095927324000379"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2024.01.019","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer\u2019s disease and related tauopathies","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2024.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Science China Press. Published by Elsevier B.V. and Science China Press.","name":"copyright","label":"Copyright"}]}}